Published in
American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. e19022-e19022
DOI: 10.1200/jco.2018.36.15_suppl.e19022
Links
Tools
Concordant extra-medullary and bone marrow disease (EMD-BM) of blastic transformation of chronic myeloid leukemia (CML-BP) in the tyrosine kinase (TKI) era: Characteristics, treatments and outcomes.
Journal article published in 2018 by
Ahmad Ghorab 
,
Hagop M. Kantarjian,
Preetesh Jain,
Rashmi Kanagal-Shamanna,
Elias Jabbour,
Koji Sasaki,
Tapan M. Kadia,
Kiran Naqvi,
Guillermo Garcia-Manero,
William G. Wierda,
Prithviraj Bose,
Srdan Verstovsek,
Nitin Jain,
Musa Yilmaz,
Zeev Estrov
and other authors.
,
Hagop M. Kantarjian,
Preetesh Jain,
Rashmi Kanagal-Shamanna,
Elias Jabbour,
Koji Sasaki,
Tapan M. Kadia,
Kiran Naqvi,
Guillermo Garcia-Manero,
William G. Wierda,
Prithviraj Bose,
Srdan Verstovsek,
Nitin Jain,
Musa Yilmaz,
Zeev Estrov
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 